BNP Paribas Financial Markets
MTNB icon

BNP Paribas Financial Markets’s Matinas BioPharma MTNB Stock Holding History

BNP Paribas Financial Markets’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$37 – 3988
2023
Q1 		– Hold
0
– – – 3803
2022
Q4 		– Hold
0
– – – 3980
2021
Q1 		– Hold
0
– -$34 – 4095
2020
Q4 		– Hold
0
– – – 4091
2020
Q3 		– Hold
0
– – – 4159
2020
Q2 		– Hold
0
– – – 4251
2020
Q1 		– Hold
0
– – – 4275
2019
Q4 		– Hold
0
– – – 4355
2019
Q3 		– Hold
0
– – – 4475
2019
Q2 		– Hold
0
– – – 4502
2019
Q1 		– Sell
-6
Closed -$4.85K – 4245
2018
Q4 		$2.85K Hold
6
– – ﹤0.01% 3733
2018
Q3 		$4.41K Hold
6
– – ﹤0.01% 4110
2018
Q2 		$2.08K Sell
6
-21
-78% -$9.1K ﹤0.01% 4249
2018
Q1 		$15.4K Buy
27
+5
+23% +$3.97K ﹤0.01% 3962
2017
Q4 		$19.3K Buy
22
+15
+214% +$14.5K ﹤0.01% 3967
2017
Q3 		$6.8K Hold
7
– – ﹤0.01% 3946
2017
Q2 		$9.35K Buy
+7
New +$14.1K ﹤0.01% 3955

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arkadios Wealth Advisors
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

BNP Paribas Financial Markets's MTNB Position: Q2 2023 in Review

BNP Paribas Financial Markets held its Matinas BioPharma (MTNB) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3988.

BNP Paribas Financial Markets first reported a position in MTNB in Q2 2017 and has held it in 7 quarters since. The position peaked at $19.3K in Q4 2017. 51 funds tracked by Wall St. Rank hold MTNB as of Q2 2023.

  • BNP Paribas Financial Markets held 0 shares of Matinas BioPharma worth $0 as of Q2 2023.
  • BNP Paribas Financial Markets left its Matinas BioPharma share count unchanged in Q2 2023.
  • Matinas BioPharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2023, its #3988 holding.
  • BNP Paribas Financial Markets first reported a position in Matinas BioPharma in Q2 2017 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Matinas BioPharma position peaked at $19.3K in Q4 2017.
  • 51 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.